Metastases in axillary sentinel lymph nodes in breast cancer as detected by intensive histopathological work up

Journal of Clinical Pathology

Volumn 52, Issue 12, 1999, Pages 922-924

  Cserni, Gábor ^a  

^a BÁCS KISKUN COUNTY TEACHING HOSPITAL   (Hungary)

Author keywords

Axillary sentinel nodes; Immunohistochemistry; Serial sectioning

Indexed keywords

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PRIORITY JOURNAL;

EID: 0033459483     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.52.12.922     Document Type: Article

References (30)

1. 1 Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977;39:456-66.
2. 2 Morton DL, Wen DR, Wong J, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
3. 3 Krag DN, Weaver DL, Alex JC, et al. Surgical resection and radiolocalization of sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993;2:335-40.
4. 4 Giuliano AE, Kirgan DM, Guenther JM, et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-8.
5. 5 Kelemen PR, Van Herle AJ, Giuliano AE. Sentinel lympadenectomy in thyroid malignant neoplasms. Arch Surg 1998;133:288-92.
6. 6 Cserni G, Boross G, Baltás B. The value of axillary sentinel nodal status in breast cancer. World J Surg (in press).
7. 7 American Joint Committee on Cancer. Breast. In: Fleming ID, Cooper JS, Henson DE, et al, eds. AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven, 1997:171-80.
8. 8 Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
9. 9 Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-50.
10. 10 Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-40.
11. 11 Jannink I, Fan M, Nagy S, et al. Serial sectioning of sentinel nodes in patients with breast cancer: a pilot study. Ann Surg Oncol 1998;5:310-14.
12. 12 Giuliano AE, Dale PS, Turner RR, et al. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;180:700-4.
13. 13 Roumen RM, Valkenburg JG, Geuskens LM. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer. Eur J Surg Oncol 1997; 23:495-502.
14. 14 Dale PS, Williams JT. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Am Surg 1998;64:28-32.
15. 15 Barnwell JM, Arredondo MA, Kollmorgen D, et al. Sentinel node biopsy in breast cancer. Ann Surg Oncol 1998;5:126-30.
16. 16 O'Hea BJ, Hill AD, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-7.
17. 17 Reuhl T, Kaisers H, Markwardt J, et al. Axillaausraumung bei klinisch nodal-negativen Mammakarzinom. Kann die Indikation durch "sentinel node" Nachweis individualisiert werden? Dtsch Med Wochenschr 1998;123:583-7.
18. 18 Koller M, Barsuk D, Zippel D, et al. Sentinel lymph node involvement - a predictor for axillary node status with breast cancer has the time come? Eur J Surg Oncol 1998; 24:166-8.
19. 19 Miner TJ, Shriver CD, Jaques DP, et al. Ultrasonographically guided injection improves localization of the radiolabeled sentinel lymph node in breast cancer. Ann Surg Oncol 1998;5:315-21.
20. 20 Krag DN, Ashikaga T, Harlow SP, et al. Development of sentinel node targeting technique in breast cancer patients. Breast J 1998;4:67-74.
21. 21 Flett MM, Going JJ, Stanton FD, et al. Sentinel node localization in patients with breast cancer. Br J Surg 1998;85: 991-3.
22. 22 Pijpers R, Meijer S, Hoekstra OS, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8.
23. 23 Veronesi U, Paganelli G, Galimberti V, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes. Lancet 1997;349:1864-7.
24. 24 Borgstein PJ, Pijpers R, Comans EF, et al. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
25. 25 Turner RR, Ollila DW, Krasne DL, et al. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-6.
26. 26 Pickren JW. Significance of occult metastases -a study of breast cancer. Cancer 1961;14:1266-71.
27. 27 Zhang PJ, Reisner RM, Nangia R, et al. Effectiveness of multiple-level sectioning in detecting axillary nodal micrometastasis in breast cancer. A retrospective study with immunohistochemical analysis. Arch Pathol Lab Med 1998; 122:687-90.
28. 28 Dowlatshahi K, Fan M, Snider HC, et al. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer 1997;80:1188-97.
29. 29 Bostick PJ, Huynh KT, Sarantou T, et al. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR. Int J Cancer 1998;79:645-51.
30. 30 Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985;312:1604-8.